CerilliantLog In | Recently Purchased | Favorites | My COAs | Cart (0)Cerilliant ISO


02-August-2010
Cerilliant Introduces New Certified Solution Standard of Dehydro Aripiprazole

Dehydro aripiprazole, D-053
1.0 mg/mL in Methanol with 5% 1N HCl

Dehydro Aripiprazole is the primary, active metabolite of aripiprazole, marketed as the atypical antipsychotic Abilify for the treatment of schizophrenia, bipolar disorder, and clinical depression. This new certified solution standard is suitable for use in LC or GC applications including forensic or clinical toxicology analysis and urine drug testing.

In addition to Aripiprazole (A-080) and its stable labeled internal standard Aripiprazole-D8 (A-081), we offer certified solution standards of other atypical antipsychotics and their metabolites and internal standards, such as quetiapine, risperidone, clozapine, ziprasidone, and olanzapine.


Cerilliant Certified Solution Standards and Certified Spiking Solutions are manufactured to the highest industry standards. We are accredited to ISO Guide 34 and ISO/IEC 17025 & certified to ISO 13485 and ISO 9001. Our quality system also incorporates cGMP and GLP requirements


All New Product Announcements


© 2018 Cerilliant Corporation | 811 Paloma Drive, Suite A | Round Rock, Texas 78665
Sigma-Aldrich is a subsidiary of Merck KGaA, Darmstadt, Germany
Products | News/Events | Sitemap | Privacy Policy | EHS Policy | Terms & Conditions | Contact
Follow Us: Cerilliant Linkedin LinkedIn